Cafepharma Today

June 20 2025 - Gene therapy faces fresh uncertainty as two more top FDA officials depart
Gene therapy faces fresh uncertainty as two more top FDA officials depart
Eli Lilly (LLY) sees strong demand for Mounjaro in India
A longer ‘winter’: Public funding slowdown heightens pressure on biotech startups
Is DTC pharma advertising coming to an end?
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Novartis, Twitter use internet to fight malaria in Africa
BioSpectrum
Tuesday, October 1, 2013 - 8:52am
tags:
Novartis, twitter, Africa, social media, malaria
Amgen Successfully Completes Onyx Pharmaceuticals Tender Offer
Yahoo
Tuesday, October 1, 2013 - 8:50am
tags:
Amgen, ONYX Pharmaceuticals, M&A
Lundbeck, Takeda Win U.S. Approval for Depression Therapy
Bloomberg
Tuesday, October 1, 2013 - 8:49am
tags:
Lundbeck, Takeda, FDA, Brintellix, major depressive disorder
Roche to show investors strength in and beyond cancer drugs
Yahoo/Reuters
Tuesday, October 1, 2013 - 8:41am
tags:
Roche, Kadcyla, antibody conjugates, MPDL3280A, lampalizumab, etrolizumab
Merck Updates Plans for Headquarters Move in New Jersey
Yahoo
Tuesday, October 1, 2013 - 8:39am
tags:
Merck
Merck to Fire 8,500 Workers in Cost-Cutting R&D Shift
Bloomberg
Tuesday, October 1, 2013 - 8:01am
tags:
Merck, R&D, layoffs
Roche's new round of lung cancer data keeps spotlight on immunotherapies
Fierce Biotech
Monday, September 30, 2013 - 5:00pm
tags:
Roche, PD-L1, non-small cell lung cancer, MPDL3280A, lung cancer
Will Arena Be Able To Write A Growth Story?
Seeking Alpha
Monday, September 30, 2013 - 4:51pm
tags:
Arena Pharmaceuticals, Vivus, Eisai
Pfizer’s Premarin for Menopause Linked to Blood Clot Risk
Bloomberg
Monday, September 30, 2013 - 4:49pm
tags:
Premarin, Pfizer, menopause
Lilly mulls options as Medicare shuns Alzheimer's diagnostic
Yahoo/AP
Monday, September 30, 2013 - 4:48pm
tags:
Eli Lilly, Medicare, Alzheimer's disease, diagnostics, Amyvid
Which Alzheimer's Fighter Will Benefit From a Boost in Federal Funding?
Motley Fool
Monday, September 30, 2013 - 4:29pm
tags:
Alzheimer's disease, LY2886721, Eli Lilly, MK-8931, Merck, bapineuzumab, JNJ, solanezumab, Gammagard, Baxter International
Can GlaxoSmithKline Reclaim Its Lost Glory In The Next Decade?
Seeking Alpha
Monday, September 30, 2013 - 4:25pm
tags:
GSK, M&A
A Thaw Between Novartis And Roche, But What Comes Next?
Forbes
Monday, September 30, 2013 - 4:20pm
tags:
Novartis, Roche
Roche breast cancer drug gets expanded U.S. pre-surgery approval
Reuters
Monday, September 30, 2013 - 12:01pm
tags:
Roche, FDA, breast cancer, Perjeta
Pfizer nabs autoimmune disease drug rights for $25M upfront
Fierce Biotech
Monday, September 30, 2013 - 11:50am
tags:
Pfizer, autoimmune disease, GL-2045, Gliknik
What happens to the FDA in a government shutdown?
Fierce Biotech
Monday, September 30, 2013 - 11:46am
tags:
FDA
Welcome to the new face of big pharma marketing - under Obamacare, big brands can become household names
AdWeek
Monday, September 30, 2013 - 11:45am
tags:
healthcare reform, DTC, Big Pharma
Pfizer: An Analysis Using Warren Buffett's 10 Points Of Light
Seeking Alpha
Monday, September 30, 2013 - 11:41am
tags:
Pfizer
Abraxane's Approval for Pancreatic Cancer Is a Major Milestone for Celgene
Motley Fool
Monday, September 30, 2013 - 11:40am
tags:
Celgene, pancreatic cancer, Abraxane
KCI, LifeCell and Systagenix to Form One Company Focused on Transformational Healing Solutions under the Leadership of President & CEO Joe Woody
CP Wire
Monday, September 30, 2013 - 11:09am
tags:
KCI, LifeCell, Systagenix, M&A, wound care, devices

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Stir Bars Can't Be Ignored
In the Pipeline
AI Effects on Drug Patents
In the Pipeline
Mirror Morphine
In the Pipeline
Vaccine Advice, Vandalized
In the Pipeline
Novo Nordisk's Canadian Mistake
In the Pipeline
The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.